Erez Israeli to join Dr. Reddy's Laboratories as COO

Image
Press Trust of India Hyderabad
Last Updated : Mar 29 2018 | 4:50 PM IST

Dr. Reddy's Laboratories Ltd. today announced the appointment of Erez Israeli, former President and CEO of Enzymotec, as the Chief Operating Officer (COO), succeeding Abhijit Mukherjee, who will retire on March 31 after a 15-year career with the company.

Israeli will join Dr. Reddy's on April two as Chief Operating Officer and Global Head of Generics & PSAI, based out of Hyderabad.

He will report to Dr. Reddy's Co-Chairman & CEO, G V Prasad, a company statement said.

In a career spanning over 25 years, Israeli has held leadership positions that have contributed significantly to the performance of companies he worked for, the statement said.

Prior to Enzymotec, he completed 23 years with Teva Pharmaceuticals Limited, where he held several positions of responsibility including Vice-President-Marketing & Sales for North America, Vice-President Asia Operations, President Teva API, Group Executive Vice President, Head of Global Quality, and President & CEO Growth Markets, it said.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Mar 29 2018 | 4:50 PM IST

Next Story